Novo Nordisk gets U.S. subpoena related to Danish factory
October 24, 2014 at 10:53 AM EDT
Oct 24 (Reuters) - Denmark's Novo Nordisk, the world's biggest maker of insulin, said on Friday it had received a U.S. subpoena requesting documents regarding potential manufacturing issues at its giant Kalundborg facility in Denmark.
